Treatment of Neurodevelopmental disorders in Adulthood

Journal of Neuroscience

Volumn 32, Issue 41, 2012, Pages 14074-14079

  Castrén, Eero ^a   Elgersma, Ype ^b   Maffei, Lamberto ^c   Hagerman, Randi ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CNR   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ARBACLOFEN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHONDROITIN ABC LYASE; FENOBAM; FLUOXETINE; FRAGILE X MENTAL RETARDATION PROTEIN; GANAXOLONE; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTINE; METABOTROPIC RECEPTOR 5; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; OCTAHYDRO 4 HYDROXY 4 [(3 METHYLPHENYL) ETHYNYL] 1H INDOLE 1 CARBOXYLIC ACID METHYL ESTER; OCTAHYDRO 4 HYDROXY 4 [(3 METHYLPHENYL)ETHYNYL] 1H INDOLE 1 CARBOXYLIC ACID METHYL ESTER; R04917523; RAS PROTEIN; SERTRALINE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULTHOOD; AMBLYOPIA; ARTICLE; AUTISM; CLINICAL TRIAL (TOPIC); DEVELOPMENTAL DISORDER; ENVIRONMENTAL ENRICHMENT; FRAGILE X SYNDROME; HUMAN; NERVE CELL PLASTICITY; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; VISUAL CORTEX;

ADULT; AGE FACTORS; ANIMALS; DEVELOPMENTAL DISABILITIES; FRAGILE X SYNDROME; GENETIC THERAPY; HUMANS; NERVOUS SYSTEM DISEASES; NEUROFIBROMATOSES; NEURONAL PLASTICITY; TREATMENT OUTCOME;

EID: 84867280540     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3287-12.2012     Document Type: Article

References (79)

1. Acler M, Robol E, Fiaschi A, Manganotti P (2009) A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 256:1152-1158. CrossRef Medline
2. Auerbach BD, Osterweil EK, Bear MF (2011) Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63-68. CrossRef Medline
3. Baroncelli L, Braschi C, Spolidoro M, Begenisic T, Maffei L, Sale A (2011) Brain plasticity and disease: a matter of inhibition. Neural Plast 2011: 286073. CrossRef Medline
4. Baroncelli L, Bonaccorsi J, Milanese M, Bonifacino T, Giribaldi F, Manno I, Cenni MC, Berardi N, Bonanno G, Maffei L, Sale A (2012) Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. Neuropharmacology 62:2388-2397. CrossRef Medline
5. Bartoletti A, Medini P, Berardi N, Maffei L (2004) Environmental enrichment prevents effects of dark-rearing in the rat visual cortex. Nat Neurosci 7:215-216. CrossRef Medline
6. Bavelier D, Levi DM, Li RW, Dan Y, Hensch TK (2010) Removing brakes on adult brain plasticity: from molecular to behavioral interventions. J Neurosci 30:14964-14971. CrossRef Medline
7. Berardi N, Pizzorusso T, Maffei L (2000) Critical periods during sensory development. Curr Opin Neurobiol 10:138-145. CrossRef Medline
8. Berardi N, Pizzorusso T, Maffei L (2004) Extracellular matrix and visual cortical plasticity: freeing the synapse. Neuron 44:905-908. CrossRef Medline
9. Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT (2008) Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 29:293-302. CrossRef Medline
10. Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R (2009) A pilot open label, single dose trial of fenobam in adults with fragileXsyndrome. J Med Genet 46:266-271. CrossRef Medline
11. Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ (2012) Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med 4:153ra127. CrossRef Medline
12. Bhakar AL, Dölen G, Bear MF (2012) The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 35:417-443. CrossRef Medline
13. Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM (2009) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94-102. Medline
14. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640. CrossRef Medline
15. Cancedda L, Putignano E, Sale A, Viegi A, Berardi N, Maffei L (2004) Acceleration of visual system development by environmental enrichment. J Neurosci 24:4840-4848. CrossRef Medline
16. Castrén M, Tervonen T, Kärkkäinen V, Heinonen S, Castrén E, Larsson K, Bakker CE, Oostra BA, Åkerman K (2005) Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci U S A 102: 17834-17839. CrossRef Medline
17. Chen JL, Lin WC, Cha JW, So PT, Kubota Y, Nedivi E (2011) Structural basis for the role of inhibition in facilitating adult brain plasticity. Nat Neurosci 14:587-594. CrossRef Medline
18. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123-130. CrossRef Medline
19. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ (2002) Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526-530. CrossRef Medline
20. Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ (2008) Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549-560. CrossRef Medline
21. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247-261. CrossRef Medline
22. de Vrij FM, Levenga J, van der Linde HC, Koekkoek SK, De Zeeuw CI, Nelson DL, Oostra BA, Willemsen R (2008) Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31:127-132. CrossRef Medline
23. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127. CrossRef Medline
24. Ehninger D, Li W, Fox K, Stryker MP, Silva AJ (2008) Reversing neurodevelopmental disorders in adults. Neuron 60:950-960. CrossRef Medline
25. Erickson CA, Mullett JE, McDougle CJ (2010) Brief report: acamprosate in fragile X syndrome. J Autism Dev Disord 40:1412-1416. CrossRef Medline
26. Galuske RA, Kim DS, Castrén E, Singer W (2000) Differential effects of neurotrophins on ocular dominance plasticity in developing and adult cat visual cortex. Eur J Neurosci 12:3315-3330. CrossRef Medline
27. Gross C, Berry-Kravis EM, Bassell GJ (2012) Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology 37:178-195. CrossRef Medline
28. Gu Q, Liu Y, Cynader MS (1994) Nerve growth factor-induced ocular dominance plasticity in adult cat visual cortex. Proc Natl Acad Sci U S A 91: 8408-8412. CrossRef Medline
29. Guzzetta A, Baldini S, Bancale A, Baroncelli L, Ciucci F, Ghirri P, Putignano E, Sale A, Viegi A, Berardi N, Boldrini A, Cioni G, Maffei L (2009) Massage accelerates brain development and the maturation of visual function. J Neurosci 29:6042-6051. CrossRef Medline
30. Hagerman R, Lauterborn J, Au J, Berry-Kravis E (2012) Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ 54:297-335. CrossRef Medline
31. Harauzov A, Spolidoro M, DiCristo G, De Pasquale R, Cancedda L, Pizzorusso T, Viegi A, Berardi N, Maffei L (2010) Reducing intracortical inhibition in the adult visual cortex promotes ocular dominance plasticity. J Neurosci 30:361-371. CrossRef Medline
32. Hensch TK (2005) Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6:877-888. CrossRef Medline
33. Heulens I, D'Hulst C, Van Dam D, De Deyn PP, Kooy RF (2012) Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res 229:244-249. CrossRef Medline
34. Huber KM, Gallagher SM, Warren ST, Bear MF (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A 99:7746-7750. CrossRef Medline
35. Hyman SL, Shores A, North KN (2005) The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65: 1037-1044. CrossRef Medline
36. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee YH, Narzisi G, Leotta A, Kendall J, Grabowska E, Ma B, Marks S, Rodgers L, Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban E, Kramer M, Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, Darnell RB, Mardis ER, Wilson RK, Schatz MC, McCombie WR, Wigler M (2012) De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-299. CrossRef Medline
37. Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, Ramos FJ, Cornish K, He Y, Paulding C, Neri G, Chen F, Hadjikhani N, Martinet D, Meyer J, Beckmann JS, Delange K, Brun A, Bussy G, Gasparini F, et al. (2011) Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 3:64ra1. CrossRef Medline
38. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67:187-196. CrossRef Medline
39. Karpova NN, Pickenhagen A, Lindholm J, Tiraboschi E, Kulesskaya N, Agústsdottir A, Antila H, Popova D, Akamine Y, Bahi A, Sullivan R, Hen R, Drew LJ, Castrén E (2011) Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334:1731-1734. CrossRef Medline
40. Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, van der Geest JN, Lequin M, Catsman CE, Arts WF, Kushner SA, Silva AJ, de Zeeuw CI, Moll HA, Elgersma Y (2008a) Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 300:287-294. CrossRef Medline
41. Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, Elgersma Y (2008b) Impact of neurofibromatosis type 1 on school performance. J Child Neurol 23:1002-1010. CrossRef Medline
42. Krab LC, Goorden SM, Elgersma Y (2008c) Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Trends Genet 24:498-510. CrossRef Medline
43. Krueger DD, Bear MF (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411-429. CrossRef Medline
44. Landi S, Sale A, Berardi N, Viegi A, Maffei L, Cenni MC (2007) Retinal functional development is sensitive to environmental enrichment: a role for BDNF. FASEB J 21:130-139. CrossRef Medline
45. Landi S, Ciucci F, Maffei L, Berardi N, Cenni MC (2009) Setting the pace for retinal development: environmental enrichment acts through insulin-like growth factor 1 and brain-derived neurotrophic factor. J Neurosci 29: 10809-10819. CrossRef Medline
46. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15:1961-1967. CrossRef Medline
47. Mainardi M, Scabia G, Vottari T, Santini F, Pinchera A, Maffei L, Pizzorusso T, Maffei M (2010) A sensitive period for environmental regulation of eating behavior and leptin sensitivity. Proc Natl Acad Sci U S A 107:16673-16678. CrossRef Medline
48. Martinowich K, Manji H, Lu B (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093. CrossRef Medline
49. Maurer D, Hensch TK (2012) Amblyopia: background to the special issue on stroke recovery. Dev Psychobiol 54:224-238. CrossRef Medline
50. Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF, Castrén E, Maffei L (2008) The Antidepressant Fluoxetine Restores Plasticity in the Adult Visual Cortex. Science 320:385-388. CrossRef Medline
51. Maya Vetencourt JF, Tiraboschi E, Spolidoro M, Castrén E, Maffei L (2011) Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur J Neurosci 33:49-57. CrossRef Medline
52. McBride SM, Choi CH, Wang Y, Liebelt D, Braunstein E, Ferreiro D, Sehgal A, Siwicki KK, Dockendorff TC, Nguyen HT, McDonald TV, Jongens TA (2005) Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45:753-764. CrossRef Medline
53. Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L (2012) Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74:49-56. CrossRef Medline
54. Morishita H, Miwa JM, Heintz N, Hensch TK (2010) Lynx1, a cholinergic brake, limits plasticity in adult visual cortex. Science 330:1238-1240. CrossRef Medline
55. Normann C, Schmitz D, Fürmaier A, Döing C, Bach M (2007) Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry 62:373-380. CrossRef Medline
56. Paribello C, Tao L, Folino A, Berry-Kravis E, Tranfaglia M, Ethell IM, Ethell DW (2010) Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol 10:91. CrossRef Medline
57. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L (2002) Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298:1248-1251. CrossRef Medline
58. Pizzorusso T, Medini P, Landi S, Baldini S, Berardi N, Maffei L (2006) Structural and functional recovery from early monocular deprivation in adult rats. Proc Natl Acad Sci U S A 103:8517-8522. CrossRef Medline
59. Putignano E, Lonetti G, Cancedda L, Ratto G, Costa M, Maffei L, Pizzorusso T (2007) Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. Neuron 53:747-759. CrossRef Medline
60. Ramocki MB, Zoghbi HY (2008) Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455:912-918. CrossRef Medline
61. Sale A, Maya Vetencourt JF, Medini P, Cenni MC, Baroncelli L, De Pasquale R, Maffei L (2007) Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition. Nat Neurosci 10:679-681. CrossRef Medline
62. Sale A, Berardi N, Maffei L (2009) Enrich the environment to empower the brain. Trends Neurosci 32:233-239. CrossRef Medline
63. Sale A, Berardi N, Spolidoro M, Baroncelli L, Maffei L (2010) GABAergic inhibition in visual cortical plasticity. Front Cell Neurosci 4:10. CrossRef Medline
64. Scali M, Begenisic T, Mainardi M, Sale A, Maffei L (2012) Chronic treatment with fluoxetine promotes recovery from cervical spinal cord injury in rats. FENS Forum abstract 1443. http://fens.ekonnect.co/FENS_331/poster_33606/program.aspx.
65. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ (2011) Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 6:e26203. CrossRef Medline
66. Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS, Ehninger D, Bearden CE, Poirazi P, Jentsch JD, Cannon TD, Levine MS, Silva AJ (2010a) Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A 107:13141-13146. CrossRef Medline
67. Shilyansky C, Lee YS, Silva AJ (2010b) Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu Rev Neurosci 33:221-243. CrossRef Medline
68. Siller SS, Broadie K (2012) Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome. Neural Plast 2012:124548. CrossRef Medline
69. Silva AJ, Frankland PW, Marowitz Z, Friedman E, Laszlo GS, Cioffi D, Jacks T, Bourtchuladze R, Lazlo G (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 15: 281-284. CrossRef Medline
70. Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN (2012) Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 4:131ra51. CrossRef Medline
71. Spolidoro M, Baroncelli L, Putignano E, Maya-Vetencourt JF, Viegi A, Maffei L (2011) Food restriction enhances visual cortex plasticity in adulthood. Nat Commun 2:320. CrossRef Medline
72. Tervonen TA, Louhivuori V, Sun X, Hokkanen ME, Kratochwil CF, Zebryk P, Castrén E, Castrén ML (2009) Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis 33:250-259. CrossRef Medline
73. Tidyman WE, Rauen KA (2009) The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19: 230-236. CrossRef Medline
74. Utari A, Chonchaiya W, Rivera SM, Schneider A, Hagerman RJ, Faradz SM, Ethell IM, Nguyen DV (2010) Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 115:433-443. CrossRef Medline
75. van der Vaart T, van Woerden GM, Elgersma Y, de Zeeuw CI, Schonewille M (2011) Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum. Genes Brain Behav 10:404-409. CrossRef Medline
76. West AE, Greenberg ME (2011) Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb Perspect Biol 3:a005744. CrossRef Medline
77. Wetmore DZ, Garner CC (2010) Emerging pharmacotherapies for neurodevelopmental disorders. J Dev Behav Pediatr 31:564-581. CrossRef Medline
78. Winarni TI, Schneider A, Borodyanskara M, Hagerman RJ (2012) Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile X syndrome. Case Rep Genet 2012:1-4. CrossRef
79. Zoghbi HY, Bear MF (2012) Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 4:a009886. CrossRef Medline